Introduction {#s0001}
============

Rotavirus (RV) was the commonest cause of acute gastroenteritis (AGE) in young children before vaccination, and had a major impact on health care systems and the quality of life of children and their families.[@cit0001] Less recognized are the effects of rotavirus infections on the central nervous system, which have been associated with seizures and other systemic manifestations.[@cit0006]

Some authors have shown that approximately 2%--7% of pediatric patients with rotavirus gastroenteritis had also seizures, either febrile or non-febrile.[@cit0011] The pathogenesis of the seizures is still unknown, although several hypotheses have been postulated.[@cit0008]^,^[@cit0015] Recently, the rotavirus non-structural protein 4 (NSP4) has been implicated in the neurological manifestations of rotavirus and serum anti-NSP4 IgGs could play a possible role in seizure protection in patients with rotavirus gastroenteritis.[@cit0010]^,^[@cit0012]^,^[@cit0015] Rotavirus-related higher levels of nitric oxide in cerebrospinal fluid,[@cit0016] and/or calcium channel fluctuations have also been described.[@cit0012]^,^[@cit0017]

Up to date the impact of RV vaccines on seizures has been poorly evaluated, with some studies but not all, showing different degrees of protection.[@cit0012]^,^[@cit0018]

Rotavirus vaccines are available in Spain since 2007. Their inclusion in national immunization programmes is strongly recommended by institutions such as the World Health Organization, the Centers for Disease Control and Prevention, and the Pediatric Spanish Society.[@cit0001]^,^[@cit0022]^,^[@cit0023] However, rotavirus vaccines are not funded by the Spanish National Health System (NHS), therefore, RV vaccines coverage rates are relatively low (around 40%).[@cit0024]^,^[@cit0025]

It is, therefore, necessary to continue the search for scientific evidence in this field. Continuation of the surveillance and further population-based studies are needed to clarify the above-mentioned findings. These studies should be designed in such a way that the results could be directly attributed to the vaccine, minimizing thus potential bias.

The present study aims to assess the specific impact of rotavirus vaccines on convulsion-related hospitalizations among children under 5 years of age residing in the Region of Valencia by using a very restricted analytical model, to control for potential confounders and avoid external bias.

Results {#s0002}
=======

Characteristics of the study population {#s0002-0001}
---------------------------------------

Among the total 295,364 hospitalizations of children \< 5 years of age in our study cohort, 9170 (3%) had a convulsion diagnosis code (780.3X ICD-9-CM). Age was related to the frequency of admissions and also to the length of stay (LOS), Almost 45% of the admissions were consisted by patients in the age group of 12 -- 24 months. Younger children had longer hospitalizations. Boys were admitted more frequently for convulsions (54%) than girls ([Table 1](#t0001){ref-type="table"}). Table 1.Descriptive analysis of cumulative hospitalizations for convulsions in children \<5 years old of The Region of Valencia between 2002 and 2015. Hospitalizations (780.3 ICD-9_CM) NumberDaysLOSAge (years)    0164410110615 14101137133.34 2201964903.21 391929553.22 448715173.11Gender    Boys5020187163.73 Girls4150160693.87[^2]

Rotavirus vaccine impact {#s0002-0002}
------------------------

Hospitalizations with a seizure diagnostic code (780.3X ICD-9-CM code) showed a decreasing trend over the study period, while the mean RV vaccine coverage increased to include up to 42.1% of the cohort. In fact, the annual hospitalization rate for convulsions in children \< 3 years was negatively correlated with RV vaccine coverage (*p* \< 0.05) ([Table 2](#t0002){ref-type="table"}). However, all-cause hospitalizations (for any cause except RVAGE and convulsions) rate decreased over the study period and was negatively correlated with the vaccination coverage (*p* \< 0.05) ([Table 2](#t0002){ref-type="table"}). Table 2.Spearman\'s correlation coefficient between rotavirus vaccine coverage, convulsions and Other hospitalizations (for any cause except RVAGE and Seizures) rates for the different age groups.AgeConvulsionsOther hosp.0−0.7395[^\*^](#t2fn0001){ref-type="fn"}−0.7465[^\*^](#t2fn0001){ref-type="fn"}1−0.9248[^\*^](#t2fn0001){ref-type="fn"}−0.8109[^\*^](#t2fn0001){ref-type="fn"}2−0.6383[^\*^](#t2fn0001){ref-type="fn"}−0.6322[^\*^](#t2fn0001){ref-type="fn"}3−0.5333−0.61674−0.5000−0.0953[^3]

The adjusted Bayesian mixed Poisson regression model was performed to assess the impact of vaccination on convulsion-related hospitalizations and to control potential bias (e.g. all-cause hospitalizations rate) ([Table 3](#t0003){ref-type="table"}). The model showed that the seizure-associated hospitalizations risk was 11% (7-15%) higher in boys than in girls ([Table 3](#t0003){ref-type="table"}). There was an age-related association of convulsion-hospitalizations, so that the highest incidence of hospitalizations was in children 1--2 years, and when the impact of vaccination against seizures was controlled for potential bias, there was a non-statistically significant protective effect ([Table 3](#t0003){ref-type="table"}). The risk of seizure-hospitalizations decreased slightly (about 5%) but not significantly in children \<5 years old and it was unrelated to vaccine coverage ([Table 3](#t0003){ref-type="table"}). Table 3.Adjusted Relative Risk (RR) of convulsions-associated hospitalizations depending on the gender, age group and vaccination coverage. Convulsions (780,3 ICD-9-CM code)Age (years)\<5Gender  Male1 Female0.89 (0.85 -- 0.93)Age group  41 02.22 (1.89 -- 2.58) 16.23 (5.60 -- 6.84) 23.39 (3.07 -- 3.75) 31.70 (1.53 -- 1.87)RV vaccine coverage  0%1 1-19%0.95 (0.88-1.03) 20-39%0.96 (0.86-1.05) ≥40%0.95 (0.84-1.08)[^4][^5]

Discussion {#s0003}
==========

In the present study we did not find the introduction of the rotavirus vaccines to have an impact on seizure-related hospitalizations in Spain, although vaccination coverage has increased up to around 40%.

RV vaccines were licensed in Spain around 2007, when the economic crisis started. This had a major impact on funding and provisioning for the healthcare system.[@cit0026] It has been described that changes in admission policies can be the result of economic constrains.[@cit0027] Accordingly, we have shown that the use of rotavirus vaccines was significantly correlated with reductions not only in convulsion-related hospitalizations, but also in all-cause hospitalizations. Therefore, when these data were analyzed, controlling for potential bias, as it is needed in observational studies and especially in ecological studies,[@cit0028] we did not find any impact of the vaccine on the prevention of seizures. The model showed a non-significant reduction in the risk of hospitalization for convulsions by around 5%, which was unrelated to vaccine coverage. Therefore, other non-controlled variables may explain these findings.

These results are in disagreement with some recent studies which showed a risk reduction in seizures in RV vaccinated populations[@cit0018]^,^[@cit0020] and in the impact on seizure-related hospitalizations.[@cit0019] The authors of these recent studies suggested that rotavirus vaccination directly prevents systemic rotavirus infection reducing thus both non-febrile[@cit0018] and febrile seizures.[@cit0019]^,^[@cit0020]

Only one other methodologically comparable ecological study[@cit0019] showed that the hospitalization rate for convulsions was negatively correlated with the rotavirus vaccination coverage in the same range with our study analysis ([Table 2](#t0002){ref-type="table"}). When they compared convulsion-related hospitalizations mean rates in the pre- and post-vaccination period, they noted a decrease between 18.7% and 42.5%.[@cit0019] Authors did not control for potential bias variables, as for the number of hospitalizations for other causes, seasonality, etc. Interestingly, we found that the impact of RV vaccines coverage on seizures disappeared in the multivariate analysis.

A retrospective analysis of a cohort of US children using the vaccine safety datalink (VSD) found that a full course of rotavirus vaccination significantly reduced the risk of seizures in children attending emergency rooms or in the hospitalized ones, by 18--21%, at least during the year following the last rotavirus vaccination. This study is not comparable with ours due to methodological differences. First, they collected data by using a larger number of ICD-9 related codes (780.3 + 779.0 + 333.2 + 345) including thus epilepsy and neonatal seizures, which may not add relevant information.[@cit0029] Second, their vaccine coverage reached 75%. Despite the differences found, the expected decrease of cases in our study should be proportional to the percentage of children vaccinated, and should reach 8 to 16% with a vaccination coverage of around 40%. Finally, it is important to highlight that these results may have some potential bias, as they had a moderate (64%) positive predictive value (PPV) in children attended in emergency room,[@cit0018]^,^[@cit0030]^,^[@cit0031] which accounted for the 68% of the study.

Sheridan et al. showed using linked databases that rotavirus vaccine was 38% effective at preventing hospitalization for febrile seizures in Australia.[@cit0020] Both groups, vaccinated and unvaccinated, as stated by the authors,[@cit0020] could differ in influenza vaccination rates, as it was more likely that children vaccinated with rotavirus vaccine would have also been vaccinated against influenza, another common cause of febrile seizures, which could lead to a possible bias. This possible bias is also presented in the USA study,[@cit0018] where, as they mentioned, they were unable to control for some other seizure-causing pathogen with similar seasonality as RV. Indeed, the influenza vaccination coverage in the USA during the study period was between 43--52%[@cit0032] and it could, therefore, have influenced seizures variations. Other authors, when estimated the RV vaccine effectiveness, controlled the variable of "other vaccines received" in order to make both groups comparable.[@cit0033]

Other studies made in Asia have also described the lack of impact of rotavirus vaccination in seizure-related hospitalizations.[@cit0012]^,^[@cit0021] They even showed a higher incidence of seizures in the post-vaccination period, potentially related to specific neurotransmitter interferences at calcium/sodium channels level or the increasing rate of rotavirus immunization and norovirus infection.[@cit0017]^,^[@cit0021]^,^[@cit0034] Supporting this hypothesis, norovirus has been increasingly reported as one of the most prevalent causes of AGE since the introduction of rotavirus vaccines,[@cit0018]^,^[@cit0037] and one of the most important causative viral agents for convulsions.[@cit0035]

Although, we have been able, with this methodology, to assess a coverage-dependent response impact of non routine vaccination on AGE,[@cit0024] our study may have some limitations. The fact that rotavirus vaccines are not funded by the Spanish health system may lead to socio-economic differences between rotavirus vaccinated and non-vaccinated populations.[@cit0004] In addition, we could have missed some data of vaccines administered in private vaccination centres not using SIV. Nonetheless, this percentage should be minimal, as a recent study showed that approximately 83% of the rotavirus vaccines distributed in Valencia were registered in SIV.[@cit0039] Data about seizures in Emergency Departments (ED) were not considered for the analysis, due to the moderate PPV of seizure codes in ED published[@cit0018] and the fact that the ethics committee did not allow to review clinical charts. Finally, our design cannot distinguish between non-febrile and febrile seizures.

In conclusion, after controlling for potential bias variables we could not find any impact of RV vaccines coverage on seizure-related hospitalizations in children \< 5 years of age.

Based on the limited number of studies and the lack of quality in some of them, there is not enough scientific evidence to ensure a direct association between RV vaccination and the prevention of seizures.

Materials and methods {#s0004}
=====================

Study settings and population {#s0004-0001}
-----------------------------

This is a retrospective population-based ecological study performed with routinely collected health data in the Valencia Region of Spain. The study included all children residing in the Region born between January 1st 2003 and December 31st 2014, aged less than 5 years. The study period lasted from the 1^st^ of January 2003 until the 30^th^ of September 2015.

The total population of The Region is approximately 5,000,000 people, with an annual birth cohort of 48,000 infants. Approximately 98.3% of the population is covered by the public health system.[@cit0040] The current regional health system consists of 24 Departments. Each of them includes at least one hospital and a number of ambulatory centres. However, this distribution has varied over the years, so we have considered for analysis the structure of 2002 consisting of 19 departments. All primary care visits and hospitalizations are recorded in clinical databases.

Data sources {#s0004-0002}
------------

The population data was obtained from the regional population-based administrative database (SIP) that collects and updates demographic data, health services assignment and usage of the health system.[@cit0041] For hospitalization, we used the hospital discharge database, MBDS (minimum basic data set)[@cit0033] that collects diagnosis and procedures as an assessment of medical activity. The coding system used is ICD-9-CM.

Case definition {#s0004-0003}
---------------

Seizure-associated hospitalizations were codified in MBDS with the ICD-9-CM code 780.3X (corresponding to convulsions).

Our outcome was: convulsion-related hospitalization, defined as hospitalization with a discharge diagnosis convulsion (ICD-9-CM code 780.3X) in any diagnosis position.

Vaccine coverage {#s0004-0004}
----------------

Vaccination coverage was defined as the proportion of the study population vaccinated with at least one dose of RV vaccines, without distinction between vaccines brands. It was obtained from the regional vaccine information system (SIV), where administered doses are registered.[@cit0033]

Statistical analysis {#s0004-0005}
--------------------

Database administrators provided the information regarding population, vaccination and hospitalizations aggregated by gender, age, year, month and health department. There was no sample size calculation as we analyzed the whole population.

In a preliminary analysis the correlation between vaccine coverage and annual admission rates for convulsions was studied. As analysis of secular trends in ecological studies may be biased for a number of reasons,[@cit0028] we also analyzed the correlation between vaccination coverage and the total hospitalizations for any cause (except for convulsions and RVAGE), by age groups, using the Spearman correlation coefficient.

As there was also a correlation between vaccination coverage and all-cause hospitalizations, a multivariate model was used to assess the impact of vaccination on monthly seizure-related hospitalization rates. This Bayesian mixed Poisson regression model controlled by age, gender, vaccine coverage (stratified in 4 groups: 0%, 1--19%, 20--39% and ≥40%), health department (as a random variable), time in months from the start of the observation period, time from vaccines licensure, and seasonality as the month of the year. The id. variable (corresponding with records from the database) was also controlled as a random effect to avoid over-dispersion.[@cit0001]^,^[@cit0024] In addition, the model was adjusted by the total hospitalization rate for all causes except convulsions (in quintiles) to decrease external bias.

The confounder variables adjustment in the multivariate model allows mitigating potential bias such as: clinical variations in medical practice among health departments, seasonality (important in seasonal illnesses as RVAGE), gender, age and population.

Results are presented with 95% credible intervals (CrI) that are comperable to 95% confidence intervals in frequentist statistics.

Analyses were carried out using R Statistical Software (Foundation for Statistical Computing, Vienna, Austria) and WinBUGS.

Conclusions
===========

We could not find any impact of RV vaccine coverage on seizure-related hospitalizations in children \<5 years.

Ethical considerations {#s0004-0006}
======================

The Ethics Research Committee of the Dirección General de Salud Pública/Centro Superior de Investigación en Salud Pública approved the study.

Disclosure of potential conflicts of interest
=============================================

JDD has been principal investigator in clinical trials sponsored by SPMSD, MSD, GSK, Pfizer. JDD acted as Advisor for GSK and SPMSD and received travel grants to attend meetings sponsored by SPMSD, MSD and GSK. AOS also received travel grants to attend meeting sponsored by MSD and Pfizer.

Authors\' contributions
=======================

AOS, JDD, MLL and CMQ contributed to the study design. MLL managed the data.

All authors participated in the analysis and interpretation of the data.

AOS drafted the manuscript.

All authors were involved in the critical revision of drafts and approved the final manuscript version.

[^1]: These authors contributed equally to the work.

[^2]: Number of hospitalizations (Number). Total days of stay (Days). Average length of stay in days (LOS).

[^3]: p-value \< 0.05

[^4]: (95% CrI)

[^5]: Poisson regression adjusted for gender, time, time in post-vaccination period, month of the year, health department and total hospitalization rate except convulsions (780.3 ICD-9).
